Posts Tagged ‘Biotechnology’
September 3rd by Tom Lydon
Traditionally defensive health care stocks and sector exchange traded funds also tap into a new...
August 31st by Tom Lydon
After stumbling in July, U.S. equities and stock exchange traded funds rallied to new highs in...
August 27th by Tom Lydon
Shaking off a spring swoon in growth stocks, the biotechnology sector exchange traded fund has...
August 25th by Tom Lydon
Monday could prove to be another day of biotechnology merger mania for the exchange traded funds...
August 21st by Tom Lydon
August 20th by Todd Shriber
It seems like only yesterday that there was a cacophony of criticism and doubt from naysayers...
July 29th by Tom Lydon
When picking an actively managed fund, people are betting on the fund manager's ability to produce...
July 26th by Todd Shriber
Even with some Friday doldrums caused by marquee names such as Visa (NYSE: V), the Dow’s largest...